Vivos Therapeutics
VVOS
VVOS
27 hedge funds and large institutions have $6.66M invested in Vivos Therapeutics in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
28% less call options, than puts
Call options by funds: $91K | Put options by funds: $126K
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Holders
27
Holding in Top 10
–
Calls
$91K
Puts
$126K
Top Buyers
| 1 | +$456K | |
| 2 | +$320K | |
| 3 | +$242K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$168K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$85.2K |
Top Sellers
| 1 | -$275K | |
| 2 | -$264K | |
| 3 | -$115K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$59K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$43K |